{
    "nctId": "NCT01814449",
    "briefTitle": "Relationship Between Hypoxia and Endocrine Response in Human Breast Cancer",
    "officialTitle": "Department of Breast Surgery And Department of Nuclear Medicine, Fudan University Shanghai Cancer Center,",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Hypoxia",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 130,
    "primaryOutcomeMeasure": "Clinical Objective Response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Postmenopausal female\n2. With primary invasive ER positive breast cancer pathologically approved by core needle biopsy\n3. The target lesion must be measurable and maximum diameter should be over 2cm.\n4. Require and accept Endocrine therapy\n5. Never treated with endocrine therapy before\n6. Patients must have an ECOG performance status of 0 to 2\n7. Leucocyte count must be \u2265 3.0\\*10\\^9/L and platelet count must be \u2265 40\\*10\\^9/L; AST/SGOT or ALT/AGPT must be \\< 2 times the ULN; serum creatinine must be \\< 2 times the ULN\n\nExclusion Criteria:\n\n1. Patients with brain and liver metastasis\n2. Previous history of severe heart dysfunction (above Class III), infection, osteoporosis, bone related event or disease in endocrine system\n3. Combination of other anticancer therapy, with the exception of biphosphonate",
    "sex": "FEMALE",
    "minimumAge": "60 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}